NCT04184089View on ClinicalTrials.gov

High Flow Nasal Cannula in Patients Undergoing ERCP Retrograde Cholangiopancreatography With Intravenous Sedation.

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

March 17, 2025

Study Completion Date

March 17, 2025

Conditions
High-flow Nasal CannulaIntravenous Sedation
Interventions
DEVICE

High flow nasal cannula (15 L/m)

nasal cannula at a flow rate of 15 l/min and FiO2 of 40%

DEVICE

High flow nasal cannula (30 L/m)

nasal cannula at a flow rate of 30l/min and FiO2 of 40%

DEVICE

High flow nasal cannula (60 L/m)

nasal cannula at flow rate of 60L/min. Oxygen supplementation will be at an FiO2 of 40%.

Trial Locations (1)

Unknown

Christian Rouphael, Beirut

All Listed Sponsors
lead

American University of Beirut Medical Center

OTHER

NCT04184089 - High Flow Nasal Cannula in Patients Undergoing ERCP Retrograde Cholangiopancreatography With Intravenous Sedation. | Biotech Hunter | Biotech Hunter